Abstract:Introduction Lung cancer screening rates in the US remain low. Evidence suggests that risk-model based approaches may outperform current risk-factor based criteria in determining screening eligibility. We compared the USPSTF 2021 lung cancer screening eligibility criteria to three existing risk prediction models in a large and racially diverse population of smoking individuals. Methods We identified current and former smokers from a predominantly Black American study population recruited from community health centers across 12 southeastern US states from 2002 to 2009 and followed until 2019. Smoking behaviors were collected by in-person interviews or mailed-in questionnaires using three follow-up surveys. Incident lung cancers were ascertained from state cancer registries and National Death Index mortality records. Screening eligibility was based on USPSTF 2021 criteria or on pre-specified risk thresholds for each risk prediction model. Performance was assessed by sensitivity (the percentage of individuals who developed lung cancer that were deemed eligible for screening) and specificity (the percentage of those without lung cancer excluded from screening). Disparities by race and sex were evaluated in each subgroup. Results Of 52,911 ever smokers (64% Black, 31% White, 4% Other), a total of 1,705 developed lung cancer. More than a third of all persons with a history of smoking were screening eligible across all models: USPSTF 41%; Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) m2012 39%; Lung Cancer Risk Assessment Tool (LCRAT) 43%; Lung Cancer Death Risk Assessment Tool (LCDRAT) 43%. All models exhibited nearly identical sensitivity (correctly identifying persons with lung cancer as eligible for screening) and specificity (excluding participants without lung cancer from screening): USPSTF Sensitivity: 0.61, Specificity: 0.59; PLCOm2012 Sensitivity: 0.62, Specificity: 0.60; LCDRAT Sensitivity: 0.62, Specificity: 0.58; LCDRAT Sensitivity: 0.60, Specificity: 0.58. Compared to Black persons with lung cancer, White persons with lung cancer were more likely to be eligible for screening across all models. Only 54-57% of Black persons with lung cancer were eligible for screening compared to 70-73% of White persons with lung cancer. The smallest racial disparities were observed using the USPSTF criteria (USPSTF sensitivity ratio for Whites to Blacks (SR [95% CI]): 1.27 [1.17-1.36]; PLCOm2012: 1.28 [1.17-1.39]; LCRAT: 1.29 [1.18-1.40]; LCDRAT: 1.33 [1.22-1.45]). There was no evidence of sex disparities greater than 1.1 RR in any of the models, with most estimated effects being less than 1+/- 0.05 RR. Conclusion In a racially diverse population of smoking individuals, we found similar performance of risk models vs USPFTF 2021 criteria for lung cancer screening. Racial disparities in screening eligibility persisted across all models, with the USPSTF 2021 criteria resulting in the smallest disparity. Given the poor performance of these models, there remains significant room for improvement. Citation Format: Adoma A. Manful, Megan H. Murray, Sarah F. Mercaldo, Jeffrey D. Blume, Melinda C. Aldrich. Are we there yet? Performance of risk-model based eligibility for lung cancer screening [abstract]. In: Proceedings of the 15th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2022 Sep 16-19; Philadelphia, PA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2022;31(1 Suppl) nr A106.

Comparison of the characteristics of the population eligible for lung cancer screening under 2013 and population newly eligible under 2021 US Preventive Services Task Force recommendations

Evaluation of Population-Level Changes Associated With the 2021 US Preventive Services Task Force Lung Cancer Screening Recommendations in Community-Based Health Care Systems

The 2021 US Preventive Services Task Force lung cancer screening eligibility criteria disproportionately exclude younger Black patients with lung cancer

Assessing disparities in lung cancer screening eligibility among high-risk individuals.

Does the revised LDCT lung cancer screening guideline bridge the racial disparities gap: Results from the health and retirement study

Evaluating Eligibility of US Black Women Under USPSTF Lung Cancer Screening Guidelines

Abstract A106: Are we there yet? Performance of risk-model based eligibility for lung cancer screening

Pack-Year Smoking History: An Inadequate and Biased Measure to Determine Lung Cancer Screening Eligibility

Trends in Subpopulations at High Risk for Lung Cancer

Assessing Information Available for Health Professionals and Potential Participants on Lung Cancer Screening Program Websites: Cross-sectional Study

The Development and Performance of Alternative Criteria for Lung Cancer Screening

Survival of lung cancer patients according to screening eligibility using Korean Lung Cancer Registry 2014–2016

Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality

Prevalence of Lung Cancer Screening in the US, 2022

Risk Factors for Lung Cancer in an Underrepresented Safety-Net Screening Cohort

Characteristics associated with early vs. late adoption of lung cancer screening

Effect of lung cancer screening on the incidence of advanced lung cancer in the United States: A SEER database analysis.

Lung Cancer Screening in Brazil Comparing the 2013 and 2021 USPSTF Guidelines

USPSTF Colorectal Cancer Screening Recommendation and Uptake for Individuals Aged 45 to 49 Years

Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study

Identifying Populations at Risk for Lung Cancer Mortality from the National Health and Nutrition Examination Survey (2001–2018) Using the 2021 USPSTF Screening Guidelines